Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.1 SEK | -7.24% | -10.48% | +88.00% |
27/05 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
27/05 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+88.00% | 7.02Cr | |
+42.69% | 75TCr | |
+38.81% | 61TCr | |
-6.87% | 35TCr | |
+18.74% | 33TCr | |
+6.76% | 29TCr | |
+18.22% | 25TCr | |
-3.07% | 21TCr | |
+10.95% | 22TCr | |
+2.64% | 17TCr |
- Stock Market
- Equities
- IRLAB A Stock
- News IRLAB Therapeutics AB
- Transcript : IRLAB Therapeutics AB, Nine Months 2022 Earnings Call, Nov 09, 2022